Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of July 10, 2026, ICCC trades at $11.46 with a market cap of $96.17M and a P/E ratio of -163.57. ICCC moved +6.11% today. Year to date, ICCC is +86.26%; over the trailing twelve months it is +69.70%. Its 52-week range spans $3.40 to $11.50. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ICCC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $11.46 |
| Market Cap | $96.17M |
| P/E Ratio | -163.57 |
| EPS | $-0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.50 |
| 52-Week Low | $3.40 |
| Volume | 47.81K |
| Avg Volume | 0 |
| Revenue (TTM) | $29.93M |
| Net Income | $-545.40K |
| Gross Margin | 42.59% |
ICCC analyst coverage data. Average price target: $0.00.